Ubroseal Blue Dry Cow 2.6 g Intramammary Suspension for Cattle

Pajjiż: Ingilterra

Lingwa: Ingliż

Sors: VMD (Veterinary Medicines Directorate)

Ingredjent attiv:

Bismuth Subnitrate

Disponibbli minn:

Univet Ltd

Kodiċi ATC:

QG52X

INN (Isem Internazzjonali):

Bismuth Subnitrate

Għamla farmaċewtika:

Intramammary suspension

Tip ta 'preskrizzjoni:

POM-V - Prescription Only Medicine – Veterinarian

Grupp terapewtiku:

Cattle

Żona terapewtika:

Miscellaneous mechanical teat seal

L-istatus ta 'awtorizzazzjoni:

Authorized

Data ta 'l-awtorizzazzjoni:

2018-02-08

Karatteristiċi tal-prodott

Unlimited renewal: July 2022
AN: 00824/2022
Page 1 of 4
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Ubroseal blue Dry Cow 2.6 g intramammary suspension for cattle
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 4g intramammary syringe contains:
Active substance:
Bismuth subnitrate, heavy
2.6g
Excipients:
Indigo Carmine AL Lake E 132
0.02g
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Intramammary suspension
Blue suspension
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle (dairy cows at drying off)
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Prevention of new intramammary infections throughout the dry period.
In cows considered likely to be free of sub-clinical mastitis, the
product can be
used on its own in dry cow management and mastitis control.
Selection of cows for treatment with the product should be based on
veterinary
clinical judgement. Selection criteria may be based on the mastitis
and cell
count history of individual cows, or recognised tests for the
detection of sub-
clinical mastitis or bacteriological sampling.
4.3
CONTRAINDICATIONS
Do not use in lactating cows. See section 4.7. Do not use the product
alone in
cows with sub-clinical mastitis at drying off. Do not use in cows with
clinical
mastitis at drying off.
Do not use in known cases of hypersensitivity to the active substance
or to any
of the excipients.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
Unlimited renewal: July 2022
AN: 00824/2022
Page 2 of 4
4.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
It is good practice to observe dry cows regularly for signs of
clinical mastitis. If a
sealed quarter develops clinical mastitis, the affected quarter should
be stripped
out manually before appropriate therapy is instituted. To reduce the
risk of
contamination, do not immerse the syringe in water. Use the syringe
only once.
It is important to observe strict aseptic technique for the
administration of the
product because the product does not have